D66-50030-42097
4 vaccinations
5 coded responses
32 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 293 / SC
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Pfizer-BioNTech
-
2021-03-23
Registered in v-safe
- 2021-03-23
- 2021-03-30
-
2021-04-06
Dose 2 — Pfizer-BioNTech
-
2021-04-07
Survey response — days 1–6 daily, dose 2MedDRA: Tremor — Feeling: Fair · Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Slight shakiness similar to an almost hypoglycemic feelingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-21
- 2021-04-27
- 2021-05-04
- 2021-05-11
-
2021-05-18
Survey response — day 42, dose 2MedDRA: Erythema, Injection site erythema, Injection site pruritus, Injection site vesicles, Pruritus, Scab — Feeling: GoodFree text: The two spots where I got the vaccines blistered and formed tiny scabs just in the last week. The only reason I noticed is that the spots were itchy. The scabs are disappearing leaving two tiny reddish spots where I got the vaccinations.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-06
-
2021-09-09
Dose 3 — Pfizer-BioNTech
-
2021-10-05
Survey response — 6 months, dose 2MedDRA: Cough, Exposure to SARS-CoV-2, Headache, Oropharyngeal pain, Pyrexia — Feeling: GoodFree text: Symptoms consistent with extremely mild covid breakthrough. Out of caution I isolated for 10 days. Symptoms were sore throat, headache, 2 day cough, low fever 1 day. Exposed to covid. Better before I could get test. Lasted 4 days. SHOTS WORK!MedDRA releases: 2024-11 · check-in free text available
- 2021-10-06
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-12-09
- 2022-03-10
-
2022-04-23
Dose 4 — Pfizer-BioNTech
- 2022-04-27
- 2022-04-28
- 2022-04-30
-
2022-05-07
Survey response — day 14, dose 4MedDRA: Nail discolouration — Feeling: GoodFree text: My toenail turned red and then black after the 2nd booster.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-14
- 2022-05-21
- 2022-05-28
- 2022-06-04
- 2022-07-23
-
2023-04-23
Survey response — 12 months, dose 4MedDRA: Asthma, COVID-19, Fatigue, Gastrointestinal disorder, Headache, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-23
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-04-24
-
2023-04-27
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech | |
| 3 | 2021-09-09 | Pfizer-BioNTech | No |
| 4 | 2022-04-23 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Slight shakiness similar to an almost hypoglycemic feeling
Release 8 — day 42, dose 2
Symptoms: The two spots where I got the vaccines blistered and formed tiny scabs just in the last week. The only reason I noticed is that the spots were itchy. The scabs are disappearing leaving two tiny reddish spots where I got the vaccinations.
Release 10 — 6 months, dose 2
Symptoms: Symptoms consistent with extremely mild covid breakthrough. Out of caution I isolated for 10 days. Symptoms were sore throat, headache, 2 day cough, low fever 1 day. Exposed to covid. Better before I could get test. Lasted 4 days. SHOTS WORK!
Release 11 — day 14, dose 4
Symptoms: My toenail turned red and then black after the 2nd booster.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site vesicles | ✓ | ✓ | ✓ |
| SD | Nail discolouration | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Scab | ✓ | ✓ | ✓ |
| SRO | Tremor | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release